Drug Type Prophylactic vaccine, mRNA vaccine |
Synonyms 新型冠状病毒 mRNA 疫苗 (玉溪沃森) |
Target |
Action inhibitors |
Mechanism SARS-CoV S protein inhibitors(SARS-CoV S protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (08 Sep 2026), |
Regulation- |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| COVID-19 | China | 08 Sep 2026 |





